DUBLIN--(BUSINESS WIRE)--Regulatory News:
Mainstay Medical International plc (Mainstay or the Company, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable neurostimulation system to treat disabling Chronic Low Back Pain, announces that Peter Crosby, Chief Executive Officer, is to present at the Innovation in Medtech Dublin 2016 Conference, to be held on 12 – 14 April 2016 at The Shelbourne Hotel in Dublin, Ireland.
